Initial evaluation on safety of herpes simplex virus Ⅰglycoprotein B DNA vaccine in mice
YU Fang,HE Bing,QIU Jun,MA Fang-qin,ZHANG Hong
DOI: https://doi.org/10.13481/j.1671-587x.2008.05.020
2008-01-01
Abstract:Objective To evaluate the safety of herpes simplex virusⅠ glycoprotein B DNA vaccine(pcDNA3-gB) in mice by examing the indexes of hematology,hematological biochemistry and pathological results of eight important organs of immunized mice.Methods Twenty-four mice were divided into four groups(n=6) randomly,including control group,100,300 and 500 mg·L-1 pcDNA3-gB groups,and 1 mL sodium chloride,100,300 and 500 mg·L-1 pcDNA3-gB were injected into mice through the quadriceps in various groups.At the 10th day after last immunity,the blood samples were collected and the indexes of hematology,hematology biochemistry and the pathological results of liver,kidney,heart,brain,spleen,cornea,retina and trigeminal ganglia were examined.Results The differences in RBC,HB,HCT,MCV,MCH,MCHC,PLT,RDW,WBC,ALT,AST,ALP,T-BIL,GLU,ALB,TP,Cr,BUN betwen control group and pcDNA3-gB groups were not significant as well as the pathological results of liver,heart,kidney,brain,spleen,cornea,retina and trigeminal ganglion(P>0.05).Conclusion pcDNA3-gB with different doses have not significant effect on the indexes of hematology,hematological biochemistry and pathology in immunized mice.It is initially proved that pcDNA3-gB is safe.